Erasca, Inc.
Erasca is a clinical-stage precision oncology company developing therapies targeting RAS/MAPK pathway-driven cancers.
10-QSep 18Latest SEC filing, period to Jun 30
Aug 11Latest story
Sign inSign inErasca is a clinical-stage precision oncology company developing therapies targeting RAS/MAPK pathway-driven cancers.